RenovoRx Share Price

RenovoRx Share Price

NASDAQ: RNXT | Micro Cap | Healthcare
$1.11
+$0.08 (7.25%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

RenovoRx Stock Performance

Open
$1.04
Prev. Close
$1.03
Circuit Range
N/A
Day Range
$1.04 - $1.15
Year Range
$0.75 - $2.57
Volume
31,135
Average Traded
$1.10

RenovoRx Share Price Today

As of 19 November 2026, RenovoRx, Inc.'s share price is $1.11. The stock opened at $1.04, compared to its previous close of $1.03. During today's trading session, RenovoRx, Inc.'s share price traded between $1.04 and $1.15, with an average price of $1.09. Over the past 52 weeks, the stock has recorded a high of $2.57 and a low of $0.75. In terms of performance, RenovoRx, Inc.'s share price has risen by 21.84% over the last six months and is up 23.33% on a year-on-year basis.

RenovoRx Share Price Chart

Line chart of the RenovoRx price trend over the selected period. The price rose overall, ranging from 1.05 to 1.15, ending at 1.11.
$1.04$1.15
L
Show Current Price
H

RenovoRx Stock Fundamentals & Key Indicators

Market Cap
$39.22M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.27
Revenue (TTM)
$1.12B
Return On Equity (TTM)
-140.24%
Profit Margin
-997.32%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-24.15%

RenovoRx Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.24$0.56$0.91$1.07
Net Profit-$2.94-$3.52-$2.91-$3.65
Net Profit Margin-1225.00%-628.57%-319.78%-341.12%
Income ChangeN/A-19.73%17.33%-25.43%

RenovoRx Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.04$1.12
Net Profit-$9.89-$10.23-$8.81-$11.17
Net Profit MarginN/AN/A-22025.00%-997.32%
Income ChangeN/A-3.44%13.88%-26.79%

RenovoRx Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.20.290.00.0
Current Assets7.897.831.477.27
Total Assets8.18.121.477.27
Non Current Liabilities0.711.733.290.0
Current Liabilities1.961.911.181.1
Total Liabilities2.673.644.471.1
Shareholders' Equity5.424.48-3.06.16

RenovoRx Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-10.97-9.13-10.26-8.81
Investing0.0-0.012.03-2.03
Financing10.8515.125.010.04

About RenovoRx

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

RenovoRx Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.28
$1.10
-17.54%
Oct 2026
$1.54
$1.34
-14.10%
Sep 2026
$1.94
$1.56
+6.12%
Aug 2026
$0.96
$1.47
+53.13%
Jul 2026
$0.97
$0.96
-2.44%
Jun 2026
$0.92
$0.98
+8.01%
May 2026
$0.88
$0.91
+6.55%
Apr 2026
$1.02
$0.85
-16.18%
Mar 2026
$0.90
$1.02
+15.91%
Feb 2026
$1.03
$0.88
-15.38%
Jan 2026
$0.86
$1.04
+23.22%
Dec 2025
$0.89
$0.84
-6.22%

RenovoRx Share Price FAQs